NovoRapid FlexPen ranks first in fast-acting human insulin pen market

Novo Nordisk’s NovoRapid FlexPen, a unique insulin pen that allows for easy injection, ranked first in the domestic fast-acting human insulin pen market during the second quarter of this year, according to IMS Health Data.

Its second-quarter market share has gained momentum, surpassing the second runner by a slight margin of 1.3 percent. NovoRapid FlexPen accounted for 35.3 percent.

As No...